| Name | Title | Contact Details |
|---|---|---|
Thomas Sutton |
Head of US Sales | Profile |
Matt Carroll |
Head of Sales Operations, North America | Profile |
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
IMCD Group is a global distributor of specialty chemicals and ingredients, headquartered in Rotterdam, Netherlands. Founded in 1995, the company is listed on the Amsterdam stock exchange and celebrated its 25th anniversary in 2020. IMCD specializes in serving various industries, including pharmaceuticals, food, personal care, coatings, and lubricants, providing formulatory solutions tailored to customer needs. The company has expanded its operations internationally, with significant growth in the Americas, including the establishment of IMCD US in 2015. IMCD Group generates approximately $4.7 billion in revenue and employs around 3,570 people worldwide. Known for its innovative approach and minimal corporate bureaucracy, IMCD maintains strong partnerships with a diverse range of suppliers and customers, from small manufacturers to large corporations.
Byers Insurance Group is a local independent agency based in Bowling Green, KY and we proudly serve the insurance needs of our customers in KY and TN. We offer home, auto, life and business insurance to our local community and surrounding areas. We pride ourselves on offering the highest level of customer service and educating our customers on the insurance products that best fit their needs. Our goal at Byers Insurance Group is to take a consultative approach with our customers so that we can fully understand what is most important to them and then craft the appropriate solution to protect what matters most! Our clients are our most important assets and we want to treat you the way we expect to be treated.
Chartered in 1901 as Irondale Bank of Irondale, MO, Unico Bank has thrived under the ownership of Leon and Barbara Brinkley for the past 30 years. Now, Unico Bank has 10 locations in Southeast Missouri and Northeast Arkansas to serve your banking needs. We pay competitive rates on deposit accounts and offer great low rates for loans to fit your needs. Visit any of our banking centers to see how Unico Bank is committed to Everyday Excellence.
Modern management software for gyms, martial arts schools, yoga studios and membership clubs.